Table 2.
Potential indications for allosteric modulators of mGluRs
compound structure | compound name (reference) |
mglur subtype |
study data |
---|---|---|---|
Pain | |||
![]() |
CPCCOEt (27) |
1 NAM | 1st allosteric modulator of an mGluR |
Anxiety, fragile X syndrome, GERD, chronic pain, depression, migraine | |||
![]() |
SIB-1757 (28) |
5 NAM | One of the first allosteric modulators of mGluR 5 |
![]() |
SIB-1893 (28) |
5 NAM | One of the first allosteric modulators of mGluR 5 |
![]() |
MPEP (29) |
5 NAM | Anxiolytic activity in animal models Established mGluR theory of fragile X syndrome |
![]() |
MTEP (30) | 5 NAM | Anxiolytic activity in animal models |
![]() |
Fenobam (34) |
5 NAM | Anxiolytic activity in animal models Efficacious in clinical trials in humans for anxiety and GERD |
![]() |
M-5MPEP (41) |
5 Partial antagonist |
One of the first partial mGluR5 antagonists |
![]() |
Br-5MPEPy (41) |
5 Partial antagonist |
One of the first partial mGluR5 antagonists |
Schizophrenia, cognition, extinction | |||
![]() |
DFB (48) | 5 PAM | Acts at MPEP site |
![]() |
CDPPB (51) | 5 PAM | Acts at MPEP site Antipsychotic-like activity in animal models |
![]() |
ADX47273 (56) | 5 PAM | Acts at MPEP site Antipsychotic-like and cognition-enhancing activity in animal models |
Anxiety disorders, schizophrenia | |||
![]() |
LY354740 (58) | 2/3 agonist |
Anxiolytic and antipsychotic activity in animal models |
![]() |
LY341495 | 2/3 antagonist |
Anxiolytic and an tipsychotic activity in animal models |
![]() |
LY487379 (66) | 2 PAM | Anxiolytic and antipsychotic activity in animal models |
![]() |
BINA (70) | 2 PAM | Anxiolytic and an tipsychotic activity in animal models |
Parkinson’s disease, movement disorders | |||
![]() |
(−)-PHCCC (86, 88) | 4 PAM | Robust activity in rodent models of PD |
![]() |
VU0155041 (87) | 4 PAM/ Allosteric agonist |
Robust activity in rodent models of PD |
GERD, gastroesophageal reflux disease; mGluR, metabotropic glutamate receptor; NAM, negative allosteric modulator; PAM, positive allosteric modulator; PD, Parkinson’s disease.